Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes.
about
Assessment and management of hypoglycemia in children and adolescents with diabetes.STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.Parental involvement buffers associations between pump duration and metabolic control among adolescents with type 1 diabetesEconomic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children - economic evaluation.Polymorphic basal rates of continuous subcutaneous insulin infusion among Taiwanese children with type 1 diabetes.New-generation diabetes management: glucose sensor-augmented insulin pump therapy.Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational studyInsulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve AbnormalityA Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitusPast, present, and future of insulin pump therapy: better shot at diabetes control.Disordered eating behaviors in youth with type 1 diabetes: prospective pilot assessment following initiation of insulin pump therapy.Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes.Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetesSafety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.An Audit of Clinical Practice in a Single Centre in Kuwait: Management of Children on Continuous Subcutaneous Insulin Infusion and Cardiovascular Risk Factors Screening.Evolution of diabetes insulin delivery devicesFactors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes.Insulin delivery by injection in children and adolescents with diabetes.Use of technology when assessing adherence to diabetes self-management behaviors.Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry.Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use.20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.A novel tool to predict youth who will show recommended usage of diabetes technologies.Condition-related predictors of successful transition from paediatric to adult care among adolescents with Type 1 diabetes.A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.Diabetes management in adolescents in poor metabolic control.Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: a 4-year follow-up study in children and adolescents with type 1 diabetes.[Comparison between continuous subcutaneous insulin infusion and multiple daily injection regimens in adolescent with type 1 diabetes from a public health care system approach to severe hypoglycemia].Assessment and monitoring of glycemic control in children and adolescents with diabetes.An Integrative Review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes.Unexplained hypoglycaemia on a pump.Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus.A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.Long-acting insulin analogues (insulin glargine or determir) and continuous subcutaneous insulin infusion in the treatment of type 1 diabetes mellitus in the paediatric population.Needle detachment in a slim and physically active child with insulin pump treatment.
P2860
Q30445990-7A71B97F-9D6B-4F5B-A3B2-D990971C00E3Q33904977-5C8DA56E-F696-435D-8B88-5BF5AF9D84FDQ34204140-9FC754CD-79EE-4AAB-BFF4-E7F51F376DD5Q35002517-53380801-983E-4021-9693-29AE82FF420CQ35087418-413BD4CB-17DE-4997-8B4E-8B6620590BD8Q35224968-866C2B5B-7876-47E2-BBD7-887C782D3108Q35765550-D43E52D8-3EC6-46FC-9F0B-A06D0E5C656AQ35981134-2B18FC5C-E40B-4094-A531-F31D31E16827Q36076863-2D76A258-3495-4A9E-BB0A-9E273DA495B3Q36282295-E555954D-AA8D-4219-9207-0E6E01F8E021Q36924597-55EC9A95-375B-45F3-A810-B13F501499FBQ36960184-BABE0753-FB3B-435D-8352-63B853319334Q36971945-15B6A44F-949A-4BE5-97E2-404C1BB00FFDQ37280760-AAF2B294-9B93-41AF-BAD1-1CE671EE8A24Q37597019-8B77F78F-A7B2-43CE-821B-DE183462B1BCQ37717437-55782536-45C3-41E9-9367-C6F014222E0EQ37761746-2ED00E7F-59DE-4654-9712-BBF5F0BC88B3Q37781112-7D2D8E10-1308-432A-A62A-9F267CC8EC44Q37863741-560EED30-E095-44B8-9157-840F131474A1Q38229366-E00F53F1-047B-4564-AC5A-0CAD96C6B7B9Q38824221-20506984-5865-41B6-8264-E586863C5009Q38879038-294C6941-8CB1-420F-BA78-73D8537CE61EQ38889745-E305190F-C7D4-4312-83FA-4095A2BA948BQ39044238-BAD63375-67EB-4266-B60D-1FC7FF291971Q41237527-BCFE72B4-77DB-4D85-AB6B-278890131201Q43289155-497498BA-C43A-44B0-83B3-9A0E8A98E0DFQ45302237-FCF8276B-BACA-4A76-ADDD-48E4C6CBEC45Q46633028-C0C1CC2E-DC56-4944-BBBA-FB6ABABA51A2Q46722924-06030463-A1F2-449A-B700-8A592BF330DEQ46834659-6E2C40D3-D13F-4774-928B-6CD092CEAC71Q46884220-DC32DB20-A10C-4988-A862-C00980EC76A1Q47673942-3D90E82E-B3FF-4BB6-ADEE-8ADDB89E9F01Q50857179-A6474D9A-CD38-463F-9991-D43F201C7CA7Q50952366-E2F410E3-790B-43C8-84B3-4124569083B4Q50987466-219F3AE5-6FA4-4C60-AB54-3C80795E2E12Q51114035-466C771A-08B9-4743-99CA-2E783A4C7701Q51292483-D865EBBE-F2D2-4704-BD3D-14CB0C9781D5Q51837766-90500AE4-609B-462E-A94C-494FA9E50550
P2860
Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@ast
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@en
type
label
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@ast
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@en
prefLabel
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@ast
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@en
P2093
P921
P1433
P1476
Safety and effectiveness of in ...... lescents with type 1 diabetes.
@en
P2093
Frederick L Brancati
Leslie P Plotnick
Loretta M Clark
Thomas Erlinger
P304
P356
10.2337/DIACARE.26.4.1142
P407
P577
2003-04-01T00:00:00Z